Tag Archives for: Health Care

Eli Lilly Buys Migraine Treatment Specialist CoLucid For $960M In Cash

From StockNews.com: Eli Lilly and Co (NYSE:LLY) will acquire CoLucid Pharmaceuticals, a maker of a cutting edge migraine headache treatment, for $960 million, the two companies announced this morning.
ETF BASIC NEWS January 18, 2017 7:28am

UnitedHealth Earnings Beat Estimates As Revenues Jump 9%

From StockNews.com: UnitedHealth Group Inc (NYSE:UNH) early Tuesday posted better-than-expected Q4 earnings results and stood by its full-year outlook, as the company's medical care ratio improved throughout 2016.
NYSE:UNH January 17, 2017 7:00am

Can Biotechs Recover From Trump’s Strong Condemnation?

From Zacks: The pharma and biotech industry is a victim of concerns over increased regulatory scrutiny on high drug prices over the past two years. The worries cooled down after Trump’s victory, and gave biotech stocks a shot in the arm.
NASDAQ:IBB January 13, 2017 9:13am

Healthcare And Biotech ETFs Continue Recovery As Money Pours In

Conventional wisdom had Hillary Clinton as “bad” for the Healthcare space, specifically the Biotechs, given her bold statements on the campaign trail in regards to reining in prescription drug costs across the segment if she were to take office.
NYSE:XLV January 11, 2017 12:10pm

VCA Inc To Be Acquired By Mars For $9.1 Billion, 31% Premium

From StockNews.com: Animal healthcare provider VCA Inc (NASDAQ:WOOF) saw its shares surge in early trading Monday, after announcing it would be acquired by privately-held candy giant Mars Inc.
NASDAQ:WOOF January 9, 2017 9:59am

Ariad Pharmaceuticals Will Be Acquired For $5.2 Billion In Cash, 75% Premium

From StockNews.com: Cancer treatment specialist Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has agreed to be acquired by Japanese biotech giant Takeda Pharmaceuticals for $24 per share in cash, in a blockbuster health care deal.

UnitedHealth Will Buy Surgical Care Affiliates For $2.35 Billion

Medical Device
From StockNews.com: Diversified healthcare giant UnitedHealth Group Inc (NYSE:UNH) is acquiring outpatient surgery facilities operator Surgical Care Affiliates (SCAI) in a cash/stock combination deal.

Health Care Was The Only Major Sector With Negative Returns Last Year

From David Fabian: When looking over the last decade of sector returns on a year-by-year basis, it’s rare to see health care fall to the bottom of the stack. Yet that unusual event is exactly what occurred in calendar year 2016.
NYSE:XLV January 5, 2017 7:18am

Biotech Downturn Underscored By Lack Of New Drug Approvals

Following the astronomical gains of the previous several years, the biotech industry was hammered in 2016. Behind the decline was a huge downturn in the approval of new medicines.
NASDAQ:IBB January 2, 2017 10:31am

Health Care Presents Unique Buying Opportunity For 2017

Medical Device
From Grant Bowers & Matthew J. Moberg: With the US stock market roaring ahead to close 2016 on a high note, the question for many investors is whether the momentum can be sustained.
NYSE:XLV December 29, 2016 11:30am

These Biotech Plays More Than Doubled This Year

From Zacks: 2016 has not been a great year for biotech stocks which were under intense pressure with issues like increasing political and media focus on high price tags for drugs and the changing competitive scenario weighing on the sector.
NASDAQ:IBB December 22, 2016 11:18am

Despite A Big Pullback, This Healthcare Stock Deserves A Look

pills healthcare 600X300
From Bob Ciura: Cardinal Health (NYSE:CAH) may not be a household name, but it deserves a place in an income investor’s portfolio.
NYSE:CAH December 6, 2016 1:14pm

Biotechs Look Dangerous Again As Trump Rally Fades

Arrow down
Biotech ETFs were initially among the biggest winners of Donald Trump's surprise election win last month, but the early euphoria has now turned to a massive sell-off once again.
NASDAQ:IBB December 2, 2016 8:23am

Report: Johnson & Johnson Boosts Bid For Actelion

In a sign that a deal could be close to being struck, healthcare products giant Johnson & Johnson (NYSE:JNJ) has reportedly upped its takeover offer for European biotech giant Actelion.
NYSE:JNJ November 29, 2016 10:56am

Recommended for You

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories